138 related articles for article (PubMed ID: 9614126)
21. Structures and interaction analyses of integrin αMβ2 cytoplasmic tails.
Chua GL; Tang XY; Amalraj M; Tan SM; Bhattacharjya S
J Biol Chem; 2011 Dec; 286(51):43842-43854. PubMed ID: 22052909
[TBL] [Abstract][Full Text] [Related]
22. Fine mapping of inhibitory anti-alpha5 monoclonal antibody epitopes that differentially affect integrin-ligand binding.
Burrows L; Clark K; Mould AP; Humphries MJ
Biochem J; 1999 Dec; 344 Pt 2(Pt 2):527-33. PubMed ID: 10567237
[TBL] [Abstract][Full Text] [Related]
23. Characterization of a novel monoclonal antibody with restricted specificity to the free beta 2 integrin alpha M CD11b subunit.
Tanfous NG; Essafi M; Larguech B; Barbouche R; Fathallah DM
Hybridoma (Larchmt); 2007 Dec; 26(6):373-9. PubMed ID: 18158781
[TBL] [Abstract][Full Text] [Related]
24. Identification of a urokinase receptor-integrin interaction site. Promiscuous regulator of integrin function.
Simon DI; Wei Y; Zhang L; Rao NK; Xu H; Chen Z; Liu Q; Rosenberg S; Chapman HA
J Biol Chem; 2000 Apr; 275(14):10228-34. PubMed ID: 10744708
[TBL] [Abstract][Full Text] [Related]
25. Effect of integrin beta 2 subunit truncations on LFA-1 (CD11a/CD18) and Mac-1 (CD11b/CD18) assembly, surface expression, and function.
Tan SM; Hyland RH; Al-Shamkhani A; Douglass WA; Shaw JM; Law SK
J Immunol; 2000 Sep; 165(5):2574-81. PubMed ID: 10946284
[TBL] [Abstract][Full Text] [Related]
26. Expression of a structural domain of the beta 2 subunit essential for alpha M beta 2 ligand recognition.
Goodman TG; DeGraaf ME; Fischer HD; Bajt ML
J Leukoc Biol; 1998 Dec; 64(6):767-73. PubMed ID: 9850159
[TBL] [Abstract][Full Text] [Related]
27. Regulation of integrin function: evidence that bivalent-cation-induced conformational changes lead to the unmasking of ligand-binding sites within integrin alpha5 beta1.
Mould AP; Garratt AN; Puzon-McLaughlin W; Takada Y; Humphries MJ
Biochem J; 1998 May; 331 ( Pt 3)(Pt 3):821-8. PubMed ID: 9560310
[TBL] [Abstract][Full Text] [Related]
28. Evidence that monoclonal antibodies directed against the integrin beta subunit plexin/semaphorin/integrin domain stimulate function by inducing receptor extension.
Mould AP; Travis MA; Barton SJ; Hamilton JA; Askari JA; Craig SE; Macdonald PR; Kammerer RA; Buckley PA; Humphries MJ
J Biol Chem; 2005 Feb; 280(6):4238-46. PubMed ID: 15557320
[TBL] [Abstract][Full Text] [Related]
29. AlphaMbeta2 (CD11b/CD18, Mac-1) integrin activation by a unique monoclonal antibody to alphaM I domain that is divalent cation-sensitive.
Orchekowski RP; Plescia J; Altieri DC; Bajt ML
J Leukoc Biol; 2000 Nov; 68(5):641-9. PubMed ID: 11073102
[TBL] [Abstract][Full Text] [Related]
30. Structure/function analysis of the integrin beta 1 subunit by epitope mapping.
Shih DT; Edelman JM; Horwitz AF; Grunwald GB; Buck CA
J Cell Biol; 1993 Sep; 122(6):1361-71. PubMed ID: 7690763
[TBL] [Abstract][Full Text] [Related]
31. The N-terminal region and the mid-region complex of the integrin beta 2 subunit.
Tan SM; Robinson MK; Drbal K; van Kooyk Y; Shaw JM; Law SK
J Biol Chem; 2001 Sep; 276(39):36370-6. PubMed ID: 11477072
[TBL] [Abstract][Full Text] [Related]
32. Identification of a novel recognition sequence for integrin alphaM beta2 within the gamma-chain of fibrinogen.
Ugarova TP; Solovjov DA; Zhang L; Loukinov DI; Yee VC; Medved LV; Plow EF
J Biol Chem; 1998 Aug; 273(35):22519-27. PubMed ID: 9712878
[TBL] [Abstract][Full Text] [Related]
33. Expression of the H52 epitope on the beta2 subunit is dependent on its interaction with the alpha subunits of the leukocyte integrins LFA-1, Mac-1 and p150,95 and the presence of Ca2+.
Al-Shamkhani A; Law SK
Eur J Immunol; 1998 Oct; 28(10):3291-300. PubMed ID: 9808198
[TBL] [Abstract][Full Text] [Related]
34. Epitopes of adhesion-perturbing monoclonal antibodies map within a predicted alpha-helical domain of the integrin beta 1 subunit.
Shih DT; Boettiger D; Buck CA
J Cell Sci; 1997 Oct; 110 ( Pt 20)():2619-28. PubMed ID: 9372451
[TBL] [Abstract][Full Text] [Related]
35. Mapping the epitope of a functional P-selectin monoclonal antibody (LYP20) to a short complement-like repeat (SCR 4) domain: use of human-mouse chimaera and homologue-replacement mutagenesis.
Ruchaud-Sparagano MH; Malaud E; Gayet O; Chignier E; Buckland R; McGregor JL
Biochem J; 1998 Jun; 332 ( Pt 2)(Pt 2):309-14. PubMed ID: 9601057
[TBL] [Abstract][Full Text] [Related]
36. Identification of the binding site for fibrinogen recognition peptide gamma 383-395 within the alpha(M)I-domain of integrin alpha(M)beta2.
Yakubenko VP; Solovjov DA; Zhang L; Yee VC; Plow EF; Ugarova TP
J Biol Chem; 2001 Apr; 276(17):13995-4003. PubMed ID: 11278633
[TBL] [Abstract][Full Text] [Related]
37. Crystal structure of the A domain from the alpha subunit of integrin CR3 (CD11b/CD18).
Lee JO; Rieu P; Arnaout MA; Liddington R
Cell; 1995 Feb; 80(4):631-8. PubMed ID: 7867070
[TBL] [Abstract][Full Text] [Related]
38. Mapping of immunogenic and protein-interacting regions at the surface of the seven-bladed beta-propeller domain of the HIV-1 cellular interactor EED.
Rakotobe D; Violot S; Hong SS; Gouet P; Boulanger P
Virol J; 2008 Feb; 5():32. PubMed ID: 18302803
[TBL] [Abstract][Full Text] [Related]
39. Critical residues for ligand binding in blade 2 of the propeller domain of the integrin alphaIIb subunit.
Tamura T; Hato T; Yamanouchi J; Fujita S
Thromb Haemost; 2004 Jan; 91(1):111-8. PubMed ID: 14691576
[TBL] [Abstract][Full Text] [Related]
40. Identification of putative ligand-binding sites of the integrin alpha 4 beta 1 (VLA-4, CD49d/CD29).
Kamata T; Puzon W; Takada Y
Biochem J; 1995 Feb; 305 ( Pt 3)(Pt 3):945-51. PubMed ID: 7531439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
